Geneseeq

Geneseeq

Private
Toronto, OntarioHealthcare & Life Scienceshttps://geneseeq.com

Last Round

Growth Equity

10/19/2020

Total Funding Raised

$489.9M

Momentum Score

25 /100

Company Overview

Geneseeq is a precision oncology company that provides genomic profiling technology to accelerate precision cancer care.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Clinical Trials, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

precision oncologynext-generation sequencingNGSgenomic profilingliquid biopsyin-vitro diagnostic kitIVD kitminimal residual disease monitoringMRD monitoringcancer diagnosticstumor profilingcancer sequencingctDNA liquid biopsycancer early detectioncancer test kitclinical trial supportbioinformatics softwareCAP/CLIA certified lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Geneseeq Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Geneseeq Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Growth Equity10/19/2020
Growth Equity1/5/2020
Series D12/26/2019
Series C11/23/2017
Series B6/1/2016

Geneseeq Investors

Notable investors and investment history

InvestorRounds
China Resources Pharmaceutical Industry Investment FundGrowth Equity
E Fund Management Co., Ltd.Series D
Lilly Asia VenturesSeries D
Ruiyi InvestmentGrowth Equity
Guangzhou Qudao Asset ManagementGrowth Equity
Shandong Hi-Speed GroupGrowth Equity
Tsing Song CapitalGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 10, 2025

    PanTRKare gene fusion kit approved by China's NMPA.

  • May 21, 2025

    Showcasing liquid biopsy research at ASCO 2025.

Geneseeq Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Geneseeq Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Geneseeq's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto, Ontario
Employee Range30
Year Founded2012
Last Funding10/19/2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.